Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Eptacog Alfa in Severe Postpartum Haemorrhage in India
NCT07157423Phase 4Recruiting
- Sponsor
- Novo Nordisk
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor VIIa in postpartum hemorrhage (PPH), sponsored by Novo Nordisk. Started Aug 2025; status: recruiting.
02
Drugs
coagulation factor VIIa
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07157423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07157423.